Patents by Inventor Peter Meerts

Peter Meerts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polypeptides inhibiting CD40L
    Patent number: 11248055
    Abstract: The present invention relates to immunoglobulins that specifically bind CD40L and more in particular to polypeptides, nucleic acids encoding such polypeptides; to methods for preparing such polypeptides; to compositions and in particular to pharmaceutical compositions that comprise such polypeptides, for prophylactic, therapeutic or diagnostic purposes. In particular, the immunoglobulins of the present invention inhibit the activity of CD40L and are safe.
    Type: Grant
    Filed: November 28, 2016
    Date of Patent: February 15, 2022
    Assignee: Ablynx N.V.
    Inventors: Els Pattyn, Ariëlla Van de Sompel, Peter Meerts, Marie-Ange Buyse, Maarten Dewilde, Gerald Beste, Jaromir Vlach, Jonathan Hsu
  • POLYPEPTIDES INHIBITING CD40L
    Publication number: 20180355050
    Abstract: The present invention relates to immunoglobulins that specifically bind CD40L and more in particular to polypeptides, nucleic acids encoding such polypeptides; to methods for preparing such polypeptides; to compositions and in particular to pharmaceutical compositions that comprise such polypeptides, for prophylactic, therapeutic or diagnostic purposes. In particular, the immunoglobulins of the present invention inhibit the activity of CD40L and are safe.
    Type: Application
    Filed: November 28, 2016
    Publication date: December 13, 2018
    Applicant: Ablynx N.V.
    Inventors: Els Pattyn, Ariëlla Van de Sompel, Peter Meerts, Marie-Ange Buyse, Maarten Dewilde, Gerald Beste, Jaromir Vlach, Jonathan Hsu
  • Fast dissolving azaperone granulate formulation
    Patent number: 9339464
    Abstract: The present invention relates to a fast dissolving granulate formulation containing the veterinary drug azaperone and a method for preparing said granulate formulation.
    Type: Grant
    Filed: June 21, 2012
    Date of Patent: May 17, 2016
    Assignee: Elanco Animal Health Ireland Limited
    Inventors: Dieter Bert Leen Ameye, Lieven Van Vooren, Peter Meerts, Geert Louise F. Van Beeck, Raja Satyanarayana Yekkala
  • Use of azaperone for reducing antibiotic usage
    Patent number: 9049874
    Abstract: The present invention relates to a method for the reduction of antibiotic usage in animals through the use of orally administered azaperone.
    Type: Grant
    Filed: September 17, 2009
    Date of Patent: June 9, 2015
    Assignee: Elanco Animal Health Ireland Limited
    Inventors: Rainier Johannes Hendrikus Van Gelderen, Peter Meerts
  • FAST DISSOLVING AZAPERONE GRANULATE FORMULATION
    Publication number: 20140128407
    Abstract: The present invention relates to a fast dissolving granulate formulation containing the veterinary drug azaperone and a method for preparing said granulate formulation.
    Type: Application
    Filed: June 21, 2012
    Publication date: May 8, 2014
    Applicant: ELANCO ANIMAL HEALTH IRELAND LIMITED
    Inventors: Dieter Bert Leen Ameye, Lieven Van Vooren, Peter Meerts, Geert Louise F. Van Beeck, Raja Satyanarayana Yekkala
  • USE OF AZAPERONE FOR REDUCING ANTIBIOTIC USAGE
    Publication number: 20110172243
    Abstract: The present invention relates to a method for the reduction of antibiotic usage in animals through the use of orally administered azaperone.
    Type: Application
    Filed: September 17, 2009
    Publication date: July 14, 2011
    Applicant: JANSSEN PHARMACEUTICA NV
    Inventors: Rainier Johannes Hendrikus Van Gelderen, Peter Meerts
  • Culturing circular ssDNA viruses for the production of vaccines
    Patent number: 7300785
    Abstract: The present invention relates to the use of interferon in the in vitro cultivation of animal circular ssDNA virus such as Porcine Circovirus 2 or human TT virus in an animal cell line. Increased titres of animal circular ssDNA virus are obtained by addition of interferons or agents which ensure the production of endogenous interferons by said cell line.
    Type: Grant
    Filed: January 31, 2006
    Date of Patent: November 27, 2007
    Assignee: Universiteit Ghent
    Inventors: Peter Meerts, Hans Nauwynck
  • CULTURING CIRCULAR SSDNA VIRUSES FOR THE PRODUCTION OF VACCINES
    Publication number: 20070161005
    Abstract: The present invention relates to the use of interferon in the in vitro cultivation of animal circular ssDNA virus such as Porcine Circovirus 2 or human TT virus in an animal cell line. Increased titres of animal circular ssDNA virus are obtained by addition of interferons or agents which ensure the production of endogenous interferons by said cell line.
    Type: Application
    Filed: January 31, 2006
    Publication date: July 12, 2007
    Inventors: Peter Meerts, Hans Nauwynck